Home/Filings/4/0001406666-23-000041
4//SEC Filing

Collins John Matthew 4

Accession 0001406666-23-000041

CIK 0001406666other

Filed

Oct 29, 8:00 PM ET

Accepted

Oct 30, 5:02 PM ET

Size

15.3 KB

Accession

0001406666-23-000041

Insider Transaction Report

Form 4
Period: 2023-10-27
Collins John Matthew
Chief Commercial Ops Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-10-27$6.95/sh+15,000$104,25015,000 total
  • Exercise/Conversion

    Common Stock

    2023-10-27$8.03/sh+15,000$120,45030,000 total
  • Exercise/Conversion

    Common Stock

    2023-10-27$9.16/sh+30,000$274,80060,000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2023-10-2715,00020,171 total
    Exercise: $6.95Exp: 2027-08-01Common Stock (15,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2023-10-2715,00025,000 total
    Exercise: $8.03Exp: 2029-02-14Common Stock (15,000 underlying)
  • Sale

    Common Stock

    2023-10-27$33.14/sh60,000$1,988,4000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2023-10-2730,000165,000 total
    Exercise: $9.16Exp: 2030-01-31Common Stock (30,000 underlying)
Footnotes (4)
  • [F1]Shares sold between $32.39 and $34.12 per share at a weighted average price of $33.14. The reporting person will provide full information regarding the number of shares sold at each sale price upon request.
  • [F2]80,000 of the shares subject to the option grant were fully vested and exercisable on July 17, 2021.
  • [F3]45,000 of the shares subject to the option grant were fully vested and exercisable on February 14, 2023.
  • [F4]175,000 of the shares subject to the option grant were fully vested and exercisable on July 31, 2023.

Issuer

CALIX, INC

CIK 0001406666

Entity typeother

Related Parties

1
  • filerCIK 0001887165

Filing Metadata

Form type
4
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 5:02 PM ET
Size
15.3 KB